These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6113314)

  • 1. The activity of enviroxime against rhinovirus infection in man.
    Phillpotts RJ; Jones RW; Delong DC; Reed SE; Wallace J; Tyrrell DA
    Lancet; 1981 Jun; 1(8234):1342-4. PubMed ID: 6113314
    [No Abstract]   [Full Text] [Related]  

  • 2. Controlled trial of enviroxime against natural rhinovirus infections in a community.
    Miller FD; Monto AS; DeLong DC; Exelby A; Bryan ER; Srivastava S
    Antimicrob Agents Chemother; 1985 Jan; 27(1):102-6. PubMed ID: 2984980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical enviroxime against rhinovirus infection.
    Levandowski RA; Pachucki CT; Rubenis M; Jackson GG
    Antimicrob Agents Chemother; 1982 Dec; 22(6):1004-7. PubMed ID: 6297380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic activity of enviroxime against rhinovirus infection in volunteers.
    Phillpotts RJ; Wallace J; Tyrrell DA; Tagart VB
    Antimicrob Agents Chemother; 1983 May; 23(5):671-5. PubMed ID: 6870216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic activity of intranasal enviroxime against experimentally induced rhinovirus type 39 infection.
    Hayden FG; Gwaltney JM
    Antimicrob Agents Chemother; 1982 Jun; 21(6):892-7. PubMed ID: 6287928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Literature review: the common cold.
    Hilding DA
    Ear Nose Throat J; 1994 Sep; 73(9):639-43, 46-7. PubMed ID: 7988393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure to demonstrate synergy between interferon-alpha and a synthetic antiviral, enviroxime, in rhinovirus infections in volunteers.
    Higgins PG; Barrow GI; al-Nakib W; Tyrrell DA; DeLong DC; Lenox-Smith I
    Antiviral Res; 1988 Nov; 10(1-3):141-9. PubMed ID: 3232968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of intranasally administered 4', 6-dichloroflavan to protect against rhinovirus infection in man.
    Al-Nakib W; Willman J; Higgins PG; Tyrrell DA; Shepherd WM; Freestone DS
    Arch Virol; 1987; 92(3-4):255-60. PubMed ID: 3545152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coming drugs against the common cold?
    Hahn FE
    Naturwissenschaften; 1979 Aug; 66(8):417-8. PubMed ID: 228206
    [No Abstract]   [Full Text] [Related]  

  • 10. Intranasal chalcone, Ro 09-0410, as prophylaxis against rhinovirus infection in human volunteers.
    Al-Nakib W; Higgins PG; Barrow I; Tyrrell DA; Lenox-Smith I; Ishitsuka H
    J Antimicrob Chemother; 1987 Dec; 20(6):887-92. PubMed ID: 3326874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral effect of 3, 4-dihydro-1-isoquinolineacetamide hydrochloride in experimental human rhinovirus infection.
    Togo Y; Schwartz AR; Hornick RB
    Antimicrob Agents Chemother; 1973 Dec; 4(6):612-6. PubMed ID: 4367686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal pirodavir (R77,975) treatment of rhinovirus colds.
    Hayden FG; Hipskind GJ; Woerner DH; Eisen GF; Janssens M; Janssen PA; Andries K
    Antimicrob Agents Chemother; 1995 Feb; 39(2):290-4. PubMed ID: 7726484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of oral 4',6-dichloroflavan to protect against rhinovirus infection in man.
    Phillpotts RJ; Wallace J; Tyrrell DA; Freestone DS; Shepherd WM
    Arch Virol; 1983; 75(1-2):115-21. PubMed ID: 6338868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purified interferon as protection against rhinovirus infection.
    Scott GM; Phillpotts RJ; Wallace J; Secher DS; Cantell K; Tyrrell DA
    Br Med J (Clin Res Ed); 1982 Jun; 284(6332):1822-5. PubMed ID: 6177374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the antirhinovirus chalcone Ro 09-0415 given orally to volunteers.
    Phillpotts RJ; Higgins PG; Willman JS; Tyrrell DA; Lenox-Smith I
    J Antimicrob Chemother; 1984 Oct; 14(4):403-9. PubMed ID: 6094423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of iota-carrageenan nasal spray versus placebo in early treatment of the common cold in adults: the ICICC trial.
    Eccles R; Winther B; Johnston SL; Robinson P; Trampisch M; Koelsch S
    Respir Res; 2015 Oct; 16():121. PubMed ID: 26438038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The limited effect of nasal interferon induced by rhinovirus and a topical chemical inducer on the course of infection.
    Gatmaitan BC; Stanley ED; Jackson GG
    J Infect Dis; 1973 Apr; 127(4):401-7. PubMed ID: 4348496
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of an alpha agonist alone and in combination with a nonsteroidal antiinflammatory agent in the treatment of experimental rhinovirus colds.
    Sperber SJ; Sorrentino JV; Riker DK; Hayden FG
    Bull N Y Acad Med; 1989 Jan; 65(1):145-60. PubMed ID: 2557947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ineffectiveness of intranasal zinc gluconate for prevention of experimental rhinovirus colds.
    Turner RB
    Clin Infect Dis; 2001 Dec; 33(11):1865-70. PubMed ID: 11692298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Wick Erste Abwehr].
    Krankenpfl J; 2004; 42(7-10):261. PubMed ID: 15675420
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.